![](/img/cover-not-exists.png)
P10 - Use of microbial biotransformation to produce scalable quantities of a glucuronidated metabolite of the clinical-stage soluble guanylate cyclase inhibitor praliciguat
Shanu-Wilson, Julia, Steele, Jonathan, Phipps, Richard, Manohar, Ravi, Karunakaran, Deepa, Borowik, Alicja, Scheffler, Frank, Evans, Liam, Carvalho, Andrew, Banijamali, AliVolume:
35
Year:
2020
Journal:
Drug Metabolism and Pharmacokinetics
DOI:
10.1016/j.dmpk.2020.04.011
File:
PDF, 48 KB
2020